Last reviewed · How we verify
Momordica Charantia Extract — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Momordica Charantia Extract (Momordica Charantia Extract) — Syamsudin Abdillah,Ph.D, Pharm D.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Momordica Charantia Extract TARGET | Momordica Charantia Extract | Syamsudin Abdillah,Ph.D, Pharm D | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Momordica Charantia Extract CI watch — RSS
- Momordica Charantia Extract CI watch — Atom
- Momordica Charantia Extract CI watch — JSON
- Momordica Charantia Extract alone — RSS
Cite this brief
Drug Landscape (2026). Momordica Charantia Extract — Competitive Intelligence Brief. https://druglandscape.com/ci/momordica-charantia-extract. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab